钙通道阻滞剂引起牙龈过度生长的发生率

Q4 Pharmacology, Toxicology and Pharmaceutics
M. Ono, Naoko Ohno, K. Hasegawa, Shigeo Tanaka, M. Komiya, H. Matsumoto, A. Fujii, Y. Akimoto
{"title":"钙通道阻滞剂引起牙龈过度生长的发生率","authors":"M. Ono, Naoko Ohno, K. Hasegawa, Shigeo Tanaka, M. Komiya, H. Matsumoto, A. Fujii, Y. Akimoto","doi":"10.11263/JSOTP1982.27.79","DOIUrl":null,"url":null,"abstract":"The incidence of gingival overgrowth caused by calcium channel blockers was determined. The overgrowth was found in patients receiving amlodipine, diltiazem, manidipine, nicardipine, nifedipine and nisoldipine. The highest rate of gingival overgrowth was obtained by nifedipine (7.6%), followed by diltiazem (4.1%), manidipine (1.8%), amlodipine (1.l%), nisoldipine (1.1%) and nicardipine (0.5%). The rate of nifedipine-induced gingival overgrowth was significantly higher than those of amlodipine, manidipine, nicardipine and nisoldipine, but not diltiazem.","PeriodicalId":19590,"journal":{"name":"Oral Therapeutics and Pharmacology","volume":"27 1","pages":"79-85"},"PeriodicalIF":0.0000,"publicationDate":"2008-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.11263/JSOTP1982.27.79","citationCount":"9","resultStr":"{\"title\":\"Incidence of gingival overgrowth caused by calcium channel blockers\",\"authors\":\"M. Ono, Naoko Ohno, K. Hasegawa, Shigeo Tanaka, M. Komiya, H. Matsumoto, A. Fujii, Y. Akimoto\",\"doi\":\"10.11263/JSOTP1982.27.79\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The incidence of gingival overgrowth caused by calcium channel blockers was determined. The overgrowth was found in patients receiving amlodipine, diltiazem, manidipine, nicardipine, nifedipine and nisoldipine. The highest rate of gingival overgrowth was obtained by nifedipine (7.6%), followed by diltiazem (4.1%), manidipine (1.8%), amlodipine (1.l%), nisoldipine (1.1%) and nicardipine (0.5%). The rate of nifedipine-induced gingival overgrowth was significantly higher than those of amlodipine, manidipine, nicardipine and nisoldipine, but not diltiazem.\",\"PeriodicalId\":19590,\"journal\":{\"name\":\"Oral Therapeutics and Pharmacology\",\"volume\":\"27 1\",\"pages\":\"79-85\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.11263/JSOTP1982.27.79\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oral Therapeutics and Pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.11263/JSOTP1982.27.79\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Therapeutics and Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11263/JSOTP1982.27.79","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 9

摘要

测定钙通道阻滞剂引起的牙龈过度生长的发生率。在使用氨氯地平、地尔硫卓、曼尼地平、尼卡地平、硝苯地平和尼索地平的患者中发现过度生长。牙龈过度生长率最高的是硝苯地平(7.6%),其次是地尔硫卓(4.1%)、曼尼地平(1.8%)、氨氯地平(1.1%)、尼索地平(1.1%)和尼卡地平(0.5%)。硝苯地平引起的牙龈过度生长率显著高于氨氯地平、曼尼地平、尼卡地平和尼索地平,但不高于地尔硫卓。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Incidence of gingival overgrowth caused by calcium channel blockers
The incidence of gingival overgrowth caused by calcium channel blockers was determined. The overgrowth was found in patients receiving amlodipine, diltiazem, manidipine, nicardipine, nifedipine and nisoldipine. The highest rate of gingival overgrowth was obtained by nifedipine (7.6%), followed by diltiazem (4.1%), manidipine (1.8%), amlodipine (1.l%), nisoldipine (1.1%) and nicardipine (0.5%). The rate of nifedipine-induced gingival overgrowth was significantly higher than those of amlodipine, manidipine, nicardipine and nisoldipine, but not diltiazem.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Oral Therapeutics and Pharmacology
Oral Therapeutics and Pharmacology Medicine-Pharmacology (medical)
CiteScore
0.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信